Oslo universitetssykehus, Aker er den delen av Oslo universitetssykehus som ligger på sykehusområdet på det som tidligere var det selvstendige sykehuset Aker. Aker sykehus var et selvstendig sykehus fra 1895 til 2008.

During the past decade, Aker University Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Aker University Hospital" #1 sponsor was "University Hospital, Aker" with 4 trials, followed by "Ferring Pharmaceuticals" with 3 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Kyowa Kirin Pharmaceutical Development Ltd" with 1 trials sponsored and "Shire" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aker University Hospital" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Diakonhjemmet Hospital" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Johanne and Einar Eilertsen's research fund" with 1 trials as a collaborator and "Josef and Haldis Andresen's legacy" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Aker University Hospital" are "Diabetes Mellitus, Type 1" (2 trials), "Prostate Cancer" (2 trials), "Biliary Tract Neoplasms" (1 trials), "Fatty Liver" (1 trials) and "Gastrointestinal Neoplasms" (1 trials). Many other conditions were trialed in "Aker University Hospital" in a lesser frequency.

Most popular intervention types in "Aker University Hospital" are "Drug" (7 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Benfotiamine" (1 trials), "Bicalutamide" (1 trials), "Degarelix" (1 trials) and "Empagliflozin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Aker University Hospital" are 8 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Aker University Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Aker University Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Aker University Hospital, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".